Nina Hunter

Nina Hunter has extensive work experience in the pharmaceutical and regulatory industries. Nina is currently the Vice President of Corporate Strategy at REGENXBIO Inc., a position they have held since July 2022. Prior to this role, they served as the Vice President of Regulatory and Science Policy at the same company, starting in May 2020. Before joining REGENXBIO Inc., Nina worked at the FDA for over 12 years, holding various roles such as Director of the Office of Clinical Policy and Programs and Deputy Director for Medical Programs. Nina also served as a Scientific Reviewer in the Office of In Vitro Diagnostics and Radiological Health.

Nina Hunter completed their Bachelor's degree in Biochemistry and English at Bowdoin College from 1995 to 1999. Nina then pursued a Doctor of Philosophy (PhD) in Genetics at Harvard Medical School from 2001 to 2007.